Ting Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ting Zhao has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Lu
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
2 shared publications Liuchunyang Yu
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
2 shared publicationsXinyi Luo
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
2 shared publicationsYang Li
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
2 shared publications- Yuanyan Liu
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China
2 shared publications Zhenglai Hua
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China
2 shared publications
Latest Publications
- 19 April 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 312, 116523
Marein reduces lipid levels via modulating the PI3K/AKT/mTOR pathway to induce lipophagy
- 19 April 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 312, 116523
Marein reduces lipid levels via modulating the PI3K/AKT/mTOR pathway to induce lipophagy
- Top Cited PapersOpen Access
- 5 May 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 150, 113074
Application and pharmacological mechanism of methotrexate in rheumatoid arthritis
- 5 May 2022
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 150, 113074
Top Cited PapersOpen AccessApplication and pharmacological mechanism of methotrexate in rheumatoid arthritis
- Open Access
- 18 January 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 807895
The Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
Tumor immune escape is a critical step in the malignant progression of tumors and one of the major barriers to immunotherapy, making immunotherapy the most promising therapeutic approach against tumors today. Tumor cells evade immune surveillance by altering the structure of their own, or by causing abnormal gene and protein expression, allowing for unrestricted development and invasion. These genetic or epigenetic changes have been linked to microRNAs (miRNAs), which are important determinants of post-transcriptional regulation. Tumor cells perform tumor immune escape by abnormally expressing related miRNAs, which reduce the killing effect of immune cells, disrupt the immune response, and disrupt apoptotic pathways. Consequently, there is a strong trend toward thoroughly investigating the role of miRNAs in tumor immune escape and utilizing them in tumor treatment. However, because of the properties of miRNAs, there is an urgent need for a safe, targeted and easily crossed biofilm vehicle to protect and deliver them in vivo, and exosomes, with their excellent biological properties, have successfully beaten traditional vehicles to provide strong support for miRNA therapy. This review summarizes the multiple roles of miRNAs in tumor immune escape and discusses their potential applications as an anti-tumor therapy. Also, this work proposes exosomes as a new opportunity for miRNA therapy, to provide novel ideas for the development of more effective tumor-fighting therapeutic approaches based on miRNAs.
- 18 January 2022
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12, 807895
Open AccessThe Role of miRNA in Tumor Immune Escape and miRNA-Based Therapeutic Strategies
Tumor immune escape is a critical step in the malignant progression of tumors and one of the major barriers to immunotherapy, making immunotherapy the most promising therapeutic approach against tumors today. Tumor cells evade immune surveillance by altering the structure of their own, or by causing abnormal gene and protein expression, allowing for unrestricted development and invasion. These genetic or epigenetic changes have been linked to microRNAs (miRNAs), which are important determinants of post-transcriptional regulation. Tumor cells perform tumor immune escape by abnormally expressing related miRNAs, which reduce the killing effect of immune cells, disrupt the immune response, and disrupt apoptotic pathways. Consequently, there is a strong trend toward thoroughly investigating the role of miRNAs in tumor immune escape and utilizing them in tumor treatment. However, because of the properties of miRNAs, there is an urgent need for a safe, targeted and easily crossed biofilm vehicle to protect and deliver them in vivo, and exosomes, with their excellent biological properties, have successfully beaten traditional vehicles to provide strong support for miRNA therapy. This review summarizes the multiple roles of miRNAs in tumor immune escape and discusses their potential applications as an anti-tumor therapy. Also, this work proposes exosomes as a new opportunity for miRNA therapy, to provide novel ideas for the development of more effective tumor-fighting therapeutic approaches based on miRNAs.